We are currently experiencing technical issues that are affecting parts of our website. If you need additional assistance, please contact membership@aabb.org.
For more information, refer to the comprehensive list of statements and comments to FDA.
REGULATORY UPDATE: FDA Issues New Guidance on COVID-19 Convalescent Plasma; AABB Toolkit Available
July 22, 2024
REGULATORY UPDATE: New AABB Toolkit Outlines Implementation Options for FDA’s New Blood Pressure and Pulse Compliance Policy
July 19, 2024
REGULATORY UPDATE: FDA Issues New Guidance on Donor Blood Pressure and Pulse Requirements
July 17, 2024